Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Repair-related molecular changes during recovery phase of ischemic stroke in female rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Changes in P2Y6 receptor-mediated vasoreactivity following focal and global ischemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Ny medicin beskytter hjernen ved voldsomme hjerneblødninger hos rotter og hunde - nu bliver den testet på danske patienter

    Publikation: Bidrag til tidsskriftBidrag til avis - AvisartikelFormidling

  4. Dual action of the cannabinoid receptor 1 ligand arachidonyl-2'-chloroethylamide on calcitonin gene-related peptide release

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Substance P (SP) and calcitonin gene-related peptide (CGRP) have both been considered potential drug candidates in migraine therapy. In recent years, CGRP receptor inhibition has been established as an effective treatment, in particular as a prophylactic for chronic migraine. Curiously, inhibition of neurokinin receptor 1 (NK1R) failed to alleviate acute migraine attacks in clinical trials, and the neurokinins were consequently abandoned as potential antimigraine candidates. The reason behind this has remained enigmatic.Utilizing immunohistochemistry and semi-quantitative cell counts the expression of neurokinins and their associated receptors was examined in the rat trigeminal ganglion.Immunohistochemistry results revealed SP co-localization in CGRP positive neurons and C-fibres, where it mainly concentrated at boutons. Neurokinin A (NKA) was observed in a population of C-fibres and small neurons where it could co-localize with SP. In contrast, neurokinin B (NKB) did not co-localize with SP and was observed in large/medium sized neurons and Aδ-fibres. All neurokinin receptors (NK1-3R) were found to be expressed in a majority of trigeminal ganglion neurons and A-fibres.The functional release of SP and CGRP in the trigeminovascular system was stimulated with either 60 mM K+ or 100 nM capsaicin and measured with an enzyme-linked immunosorbent assay (ELISA). ELISA results established that SP can be released locally from trigeminovascular system. The released SP was comparatively minor compared to the CGRP release from stimulated dura mater, trigeminal ganglion neurons and fibres. We hypothesize that SP and CGRP signalling pathways may work in tandem to exacerbate painful stimuli in the TGV system.

TidsskriftMolecular Pain
Sider (fra-til)17448069211059400
Antal sider11
StatusUdgivet - 14 dec. 2021

ID: 70122173